Enhanced oral bioavailability of puerarin using microemulsion vehicle

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 138-144

  Wu, Hongfei ^a   Lu, Chuanhua ^a   Zhou, An ^a   Min, Zhiwei ^a   Zhang, Yulian ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bioavailability; Microemulsion; Pharmacokinetics; Puerarin

Indexed keywords

LACTIC ACID ETHYL ESTER; PHOSPHATIDYLCHOLINE; PROPYLENE GLYCOL; PUERARIN; SOYBEAN OIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STABILITY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICROEMULSION; MOUSE; NONHUMAN; SPECTROSCOPY; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; ISOFLAVONES; MEDICINE, CHINESE TRADITIONAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SOLUBILITY; SURFACE-ACTIVE AGENTS; VASODILATOR AGENTS; VEHICLES;

EID: 60749088312     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801973495     Document Type: Article

References (25)

1. Brocks, D. R., Ala, S., & Aliabadi, H. M. (2006). The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat. Biopharm. Drug Dispos., 27, 7-16.
2. Charman, W. N., & Stella, V. J. (1991). Transport of lipophilic molecules by the intestinal lymphatic system. Adv. Drug Deliv. Rev., 7, 1-14.
3. Eccleston, J. (1994). Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker.
4. Gao, F. Y. (2003). Advances of pharmacological effects of Puerarin. Chin. Tradit. Herb Drug, 34, 7-8.
5. Gershanik, T., & Benita, S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm., 50, 179-188.
6. Gershkovich, P., Shtainer, D., & Hoffman, A. (2007). The effect of a high-fat meal on the pharmacodynamics of a model lipophilic compound that binds extensively to triglyceride-rich lipoproteins. Int. J. Pharm., 333, 1-4.
7. Humberstone, A. J., & Charman, W. N. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev., 25, 103-128.
8. Jin, X. L., Cheng, G. F., & Zhu, X. Y. (1991). Pharmacokinetics of Puerarin in Voluteers. China J. Clin. Pharmacol., 7, 115-118.
9. Lawrence, M. J., & Rees, G. D. (2000). Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 45, 89-121.
10. Li, Y., Pan, W. S., Chen, S. L., Yang, D. J., Chen, X. Z., & Xu, H. X. (2006). Studies on preparation of Puerarin phytosomes and their solid dispersions. Chin. Pham. J., 41, 1162-1167.
11. Lundin, P. D., Bojrup, M., Ljusberg-Wahren, H., Westrom, B. R., & Lundin, S. (1997). Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles onintestinal absorption of desmopressin (dDAVP). Pharmcol. Exp. Ther., 282, 585-590.
12. Lindmark, T., Schipper, N., Lazorova, L., de Boer, A. G., & Artursson, P. (1998). Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: Assessment of molecular weight dependence and demonstration of transport routes. Drug Target., 5, 215-223.
13. Moulik, J. M. & Paul, B. K. (1998). Structure, dynamics and transport properties of microemulsion. Adv. Colloid Interface Sci., 78, 99-195.
14. O'Driscoll, C. M. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci., 15, 405-415.
15. Robinson, J. R. (1978). Sustained and controlled release drug delivery systems (pp. 71-121). New York: Marcel Dekker.
16. Swenson, E. S., & Curatolo, W. J. (1992). Means to enhance penetration. Adv. Drug Deliv. Rev., 8, 39-42.
17. Shayeganpour, A., Jun, A. S., & Brocks, D. R. (2005). Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharm. Drug Dispos., 26, 249-257.
18. Schwuger, M. J., & Stickdorn, K. (1995). Microemulsion in technical processes. Chem. Rev., 95, 849-864.
19. Shi, R. L., & Zhang, J. J. (2003). Protective effect of Puerarin on vascular endothelial cell apoptosis induced by chemical hypoxia in vitro. Acta Pharm. Sin., 38, 103-107.
20. Tang, Z. S., Guo, D. Y., & Rong, Y. (2005). Bioavailability investigation of Pur-powder and micro-powder in Beagle dogs. Liaoning Tradit. Chin. Med., 32, 830-831.
21. Wang, Z., Yang, C. Y., Lu, L. F., & Zhu, J. B. (1997). Studies on absorptive mechanism of Insulin in oral microemulsion. J. Chin. Pharm. Uni., 28, 23-325.
22. Yamamoto, A., Okagawa, T., & Kotani, A. (1997). Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. Pharm. Pharmacol., 49, 1057-1061.
23. Zhang, Z. R., You, X. J., Wei, Z. P., He, Q., & Li, Z. W. (1997). Pharmacokinetics and bioavailability of Yufeng Ningxin tablet in rabbits[J]. Chin. Pharm. J., 32, 224-226.
24. Zhu, X. Y. (1979). Pharmacokinetics of Puerarin. Acta Pharm. Sin., 17, 349.
25. Zhou, Y. S., Jia, Y. Y., Shen, X. Q., Zhu, X. C., Gao, S., & Wu, A. L. (2003). Studies on preparation and in vitro evaluation of Puerarin solid dispersions. Chin. Pharm., 38, 42-44.